Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and sézary syndrome: A European society for blood and marrow transplantation lymphoma working party extended analysis

Journal of Clinical Oncology

Volumn 32, Issue 29, 2014, Pages 3347-3348

  Duarte, Rafael F ^a   Boumendil, Ariane ^b   Onida, Francesco ^c   Gabriel, Ian ^d   Arranz, Reyes ^e   Arcese, William ^f   Poiré, Xavier ^g   Kobbe, Guido ^h   Narni, Franco ⁱ   Cortelezzi, Agostino ^j   Olavarría, Eduardo ^k   Schmitz, Norbert ^l   Sureda, Anna ^a   Dreger, Peter ^c,m  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b European Society for Blood and Marrow Transplantation   (France)

^c EBMT Lymphoma Working Party   (France)

^d UNIVERSITY OF MILAN   (Italy)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k Instituto de Investigación Sanitaria de Navarra   (Spain)

^l DEPARTMENT OF CARDIOLOGY   (Germany)

^m UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVOR; CHRONIC PATIENT; DONOR LYMPHOCYTE INFUSION; FEMALE; FOLLOW UP; HUMAN; LETTER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; REDUCED INTENSITY CONDITIONING; SALVAGE THERAPY; SEZARY SYNDROME; T CELL DEPLETION; TREATMENT RESPONSE; UNRELATED DONORS; ALLOTRANSPLANTATION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; SEZARY SYNDROME; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84907479655     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.57.5597     Document Type: Letter

References (5)

1. Duarte RF, Canals C, Onida F, et al: Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: A retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 28:4492-4499, 2010
2. Olsen E, Vonderheid E, Pimpinelli N, et al: Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:1713-1722, 2007
3. Lechowicz MJ, Agovi M, Carreras J, et al: Allogeneic hematopoietic cell transplantation (AHCT) for primary cutaneous T cell lymphoma (CTCL): A Center for International Blood and Marrow Transplant Research (CIBMTR) review. Blood 116, 2010
4. de Masson A, Beylot-Barry M, Bouaziz JD, et al: Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: A study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. Haematologica 99:527-534, 2014
5. Jacobsen ED, Kim HT, Ho VT, et al: A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome. Ann Oncol 22:1608-1613, 2011.